| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Jun 15, 2023 | Replimune Group, Inc. | Chief Dev. Op. Officer | Sell | 26.3 | -12,860 | -8.68% | ✓ | $309.4K |
| May 16, 2023 | May 18, 2023 | Replimune Group, Inc. | Chief Dev. Op. Officer | Sell | 42.5 | -12,207 | -7.61% | ✗ | $220.3K |
| May 16, 2022 | May 18, 2022 | Replimune Group, Inc. | Chief Dev. Op Officer | Sell | 42.5 | -5,473 | -4.35% | ✗ | $79.9K |
| Feb 11, 2021 | Feb 17, 2021 | Karyopharm Therapeutics Inc. | EVP, Chief Reg. Affairs | Sell | 46.3 | -2,046 | -33.06% | ✗ | $31.8K |
| Oct 28, 2020 | Nov 4, 2020 | Karyopharm Therapeutics Inc. | EVP,Chief Reg.&Quality Officer | Sell | 47.5 | -226 | -29.54% | ✗ | $3.5K |